Drug
Zocaglusagene Nuzaparvovec
Zocaglusagene Nuzaparvovec: highest development phase Phase 1/2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| zocaglusagene nuzaparvovec NCT04174105 | Phase 1/2 | Pompe Disease (Late-onset) |
Latest
No recent events.
Follow Zocaglusagene Nuzaparvovec on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.